Autonomix Medical Inc (AMIX)

$0.53 +0.03 (5.98%)
Market Cap 3.49M
Revenue (ttm) 0.00
Net Income (ttm) -11.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 561,900
Avg Vol 10,321,834
Day's Range N/A - N/A
Shares Out 6.91M
Stochastic %K 20%
Beta -2.59
Analysts Strong Sell
Price Target $6.60

Company Profile

Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company's technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related diso...

Industry: Medical Devices
Sector: Healthcare
Phone: 713 588 6150
Address:
21 Waterway Avenue, Suite 300, The Woodlands, United States
GaryBx105
GaryBx105 Jan. 14 at 9:00 PM
$AMIX huge potential vs ongoing dilution. dilution winning - until today. maybe a turning point.
0 · Reply
darknite222
darknite222 Jan. 14 at 5:31 PM
$AMIX news update
0 · Reply
RISE07
RISE07 Jan. 14 at 4:41 PM
$AMIX I think something will happen after the J.P Morgan healthcare conference finish 🤔
0 · Reply
rangervs
rangervs Jan. 14 at 4:30 PM
$ROLR she’s moving! $AMIX bounce needs to happen!
0 · Reply
dwhall5056
dwhall5056 Jan. 14 at 2:22 PM
$AMIX looks like the dark pool has covered most of their shares ... https://fintel.io/ss/us/amix
0 · Reply
coolmate25
coolmate25 Jan. 14 at 4:31 AM
$AMIX This stock has been shortened to death already, I mean enough is enough. I have already disabled my stock lending and will request all investors and traders to disabled it too so that we can get something out of shorts squeeze.
0 · Reply
coolmate25
coolmate25 Jan. 13 at 8:02 PM
$AMIX All we need is a millionaire to invest on this hostoric dip and get multi-milliinare. Tax return comings.
0 · Reply
coolmate25
coolmate25 Jan. 13 at 6:12 PM
$AMIX Good price to buy right now . I wish if i had 100k right now.
0 · Reply
RISE07
RISE07 Jan. 13 at 5:43 PM
$AMIX buy and hold
0 · Reply
rangervs
rangervs Jan. 13 at 5:26 PM
$MNTS kept 1500 , promising $UAVS holding strong most of the day /will add more $AMIX near 52 week low , should bounce
0 · Reply
Latest News on AMIX
Autonomix Showcases Compelling PoC Study Clinical Data Showing Rapid and Durable Pain Relief Across All Disease Stages of Pancreatic Cancer at the 2026 ASCO Gastrointestinal (GI) Cancers Symposium

Jan 9, 2026, 8:45 AM EST - 5 days ago

Autonomix Showcases Compelling PoC Study Clinical Data Showing Rapid and Durable Pain Relief Across All Disease Stages of Pancreatic Cancer at the 2026 ASCO Gastrointestinal (GI) Cancers Symposium

Autonomix Medical, Inc. (NASDAQ: AMIX) Highlights Expanding IP Portfolio and Multi-Indication Platform Strategy in Virtual Investor CEO Connect Segment

Dec 23, 2025, 8:45 AM EST - 22 days ago

Autonomix Medical, Inc. (NASDAQ: AMIX) Highlights Expanding IP Portfolio and Multi-Indication Platform Strategy in Virtual Investor CEO Connect Segment

Autonomix Medical, Inc. Announces Abstract Selected for Poster Presentation at the 2026 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium

Dec 18, 2025, 8:30 AM EST - 27 days ago

Autonomix Medical, Inc. Announces Abstract Selected for Poster Presentation at the 2026 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium

Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment Highlighting Continued Execution and Strategic Growth

Nov 26, 2025, 8:45 AM EST - 7 weeks ago

Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment Highlighting Continued Execution and Strategic Growth

Autonomix Medical, Inc. Featured in Two Innovation in Interventional Cardiology Podium Presentations at the Transcatheter Cardiovascular Therapeutics® (TCT®) Annual Scientific Conference

Oct 24, 2025, 9:00 AM EDT - 2 months ago

Autonomix Medical, Inc. Featured in Two Innovation in Interventional Cardiology Podium Presentations at the Transcatheter Cardiovascular Therapeutics® (TCT®) Annual Scientific Conference

Autonomix Medical, Inc. to Highlight Innovative Nerve-Sensing and Ablation Platform at the 2025 Maxim Growth Summit

Oct 16, 2025, 9:15 AM EDT - 3 months ago

Autonomix Medical, Inc. to Highlight Innovative Nerve-Sensing and Ablation Platform at the 2025 Maxim Growth Summit

Autonomix Medical, Inc. Granted U.S. Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in Cardiology

Oct 9, 2025, 8:45 AM EDT - 3 months ago

Autonomix Medical, Inc. Granted U.S. Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in Cardiology

Autonomix Medical, Inc. Announces Release of the Next CEO Corner Segment

Oct 2, 2025, 8:45 AM EDT - 3 months ago

Autonomix Medical, Inc. Announces Release of the Next CEO Corner Segment

Autonomix Medical, Inc. Initiates Good Laboratory Practice (GLP) Study for Sensing and RF Ablation System

Sep 29, 2025, 9:15 AM EDT - 3 months ago

Autonomix Medical, Inc. Initiates Good Laboratory Practice (GLP) Study for Sensing and RF Ablation System

Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment

Sep 4, 2025, 9:00 AM EDT - 4 months ago

Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment

Autonomix Medical, Inc. Demonstrates Sustained Pain Reduction, Quality of Life Gains and 100% Zero Opioid Use in Longer-Term Post Hoc Analysis from PoC 1 Study

Sep 3, 2025, 8:30 AM EDT - 4 months ago

Autonomix Medical, Inc. Demonstrates Sustained Pain Reduction, Quality of Life Gains and 100% Zero Opioid Use in Longer-Term Post Hoc Analysis from PoC 1 Study

Autonomix Medical, Inc. to Present at H.C. Wainwright 27th Annual Global Investment Conference

Sep 2, 2025, 8:30 AM EDT - 4 months ago

Autonomix Medical, Inc. to Present at H.C. Wainwright 27th Annual Global Investment Conference

Autonomix Medical, Inc. to Participate in Virtual Investor Webinar Hosted by Ladenburg Thalmann & Co. Inc.

Aug 18, 2025, 9:15 AM EDT - 5 months ago

Autonomix Medical, Inc. to Participate in Virtual Investor Webinar Hosted by Ladenburg Thalmann & Co. Inc.

Autonomix Medical, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

Aug 15, 2025, 9:00 AM EDT - 5 months ago

Autonomix Medical, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

Autonomix Medical, Inc. Finalizes Design Review of First-Ever Intravascular Nerve Sensing Catheter in Key Step Toward U.S. Clinical Studies

Aug 14, 2025, 8:30 AM EDT - 5 months ago

Autonomix Medical, Inc. Finalizes Design Review of First-Ever Intravascular Nerve Sensing Catheter in Key Step Toward U.S. Clinical Studies

Autonomix Medical, Inc. Participates in the Virtual Investor “What's Your Story” Summer Spotlight On-Demand Conference

Jul 22, 2025, 8:45 AM EDT - 6 months ago

Autonomix Medical, Inc. Participates in the Virtual Investor “What's Your Story” Summer Spotlight On-Demand Conference

Autonomix Medical, Inc. Granted New U.S. Patent to Advance Minimally Invasive, Nerve-Focused Treatments Across High-Need Indications

Jul 21, 2025, 8:45 AM EDT - 6 months ago

Autonomix Medical, Inc. Granted New U.S. Patent to Advance Minimally Invasive, Nerve-Focused Treatments Across High-Need Indications

Autonomix Medical, Inc. Treats First Patient in Follow-On Market Expansion Phase (“PoC 2”) of Proof-of-Concept Human Clinical Study

Jun 30, 2025, 8:30 AM EDT - 7 months ago

Autonomix Medical, Inc. Treats First Patient in Follow-On Market Expansion Phase (“PoC 2”) of Proof-of-Concept Human Clinical Study

Autonomix Medical, Inc. Granted New U.S. Patent for Innovative Catheter-Based Platform Technology

Jun 27, 2025, 8:00 AM EDT - 7 months ago

Autonomix Medical, Inc. Granted New U.S. Patent for Innovative Catheter-Based Platform Technology

Autonomix Medical, Inc. Granted Approval to Expand Proof-of-Concept Human Clinical Study, Doubling Potential Addressable Market Beyond Pancreatic Cancer Pain

Jun 5, 2025, 8:45 AM EDT - 7 months ago

Autonomix Medical, Inc. Granted Approval to Expand Proof-of-Concept Human Clinical Study, Doubling Potential Addressable Market Beyond Pancreatic Cancer Pain

Autonomix Medical, Inc. Granted Key U.S. Patent for Innovative Catheter-Based Platform Technology

May 15, 2025, 8:30 AM EDT - 8 months ago

Autonomix Medical, Inc. Granted Key U.S. Patent for Innovative Catheter-Based Platform Technology

Autonomix CEO Brad Hauser to Present at Virtual Investor's Closing Bell Event

May 14, 2025, 9:20 AM EDT - 8 months ago

Autonomix CEO Brad Hauser to Present at Virtual Investor's Closing Bell Event

Brad Hauser, CEO of Autonomix Medical, Inc. Outlines Follow-On Expansion Study Expected to Begin in Q2 2025, Potentially Doubling Addressable Market

May 13, 2025, 9:20 AM EDT - 8 months ago

Brad Hauser, CEO of Autonomix Medical, Inc. Outlines Follow-On Expansion Study Expected to Begin in Q2 2025, Potentially Doubling Addressable Market

Autonomix Highlights Compelling Patient Testimonial Showing Rapid Pain Relief from First-in-Human Proof-of-Concept Trial in Pancreatic Cancer Pain

May 5, 2025, 8:30 AM EDT - 9 months ago

Autonomix Highlights Compelling Patient Testimonial Showing Rapid Pain Relief from First-in-Human Proof-of-Concept Trial in Pancreatic Cancer Pain

Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment Highlighting Key Learnings from First-In-Human Trial and Extension into Visceral Cancer Pain

May 1, 2025, 9:25 AM EDT - 9 months ago

Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment Highlighting Key Learnings from First-In-Human Trial and Extension into Visceral Cancer Pain

Autonomix Medical, Inc. Reports Positive Outcomes in Initial Phase of First-in-Human Proof-of-Concept Trial in Pancreatic Cancer Pain and Initiates Market Expansion Study for Visceral Cancer Pain

Apr 30, 2025, 8:15 AM EDT - 9 months ago

Autonomix Medical, Inc. Reports Positive Outcomes in Initial Phase of First-in-Human Proof-of-Concept Trial in Pancreatic Cancer Pain and Initiates Market Expansion Study for Visceral Cancer Pain

Autonomix Medical, Inc. Technology and Early Proof-of-Concept Study Results to be Featured in Poster Presentation at the World-Leading Course in Interventional Cardiovascular Medicine, EuroPCR

Apr 24, 2025, 8:30 AM EDT - 9 months ago

Autonomix Medical, Inc. Technology and Early Proof-of-Concept Study Results to be Featured in Poster Presentation at the World-Leading Course in Interventional Cardiovascular Medicine, EuroPCR

Autonomix Medical, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Apr 17, 2025, 5:00 PM EDT - 9 months ago

Autonomix Medical, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Autonomix Medical, Inc. Granted New European Patent for Proprietary Catheter-Based Technology

Apr 16, 2025, 8:30 AM EDT - 9 months ago

Autonomix Medical, Inc. Granted New European Patent for Proprietary Catheter-Based Technology

Autonomix Medical, Inc. Engages Leading Medical Experts to Guide U.S. Clinical and Regulatory Path in Pancreatic Cancer Pain

Apr 8, 2025, 8:15 AM EDT - 10 months ago

Autonomix Medical, Inc. Engages Leading Medical Experts to Guide U.S. Clinical and Regulatory Path in Pancreatic Cancer Pain

Autonomix Medical, Inc. to Highlight Technology and Early Proof-of-Concept Study Results in a Poster Presentation at the 2025 European Conference on Interventional Oncology (ECIO)

Apr 3, 2025, 8:30 AM EDT - 10 months ago

Autonomix Medical, Inc. to Highlight Technology and Early Proof-of-Concept Study Results in a Poster Presentation at the 2025 European Conference on Interventional Oncology (ECIO)

Autonomix Medical, Inc. Granted U.S. Patent Covering Sensing Data Collection and Processing with Company's Proprietary Catheter-Based Technology

Mar 20, 2025, 8:30 AM EDT - 10 months ago

Autonomix Medical, Inc. Granted U.S. Patent Covering Sensing Data Collection and Processing with Company's Proprietary Catheter-Based Technology

Autonomix Medical, Inc. Advances Toward U.S. Clinical Trials in 2025 with Completed Integration of Apex 6 Generator for Transvascular Ablation

Mar 14, 2025, 8:30 AM EDT - 10 months ago

Autonomix Medical, Inc. Advances Toward U.S. Clinical Trials in 2025 with Completed Integration of Apex 6 Generator for Transvascular Ablation

Autonomix Medical, Inc. Selected for Podium Presentation at the 2025 CRT Annual Meeting

Feb 20, 2025, 8:30 AM EST - 11 months ago

Autonomix Medical, Inc. Selected for Podium Presentation at the 2025 CRT Annual Meeting

Autonomix Medical, Inc. Reports Third Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update

Feb 13, 2025, 8:00 AM EST - 11 months ago

Autonomix Medical, Inc. Reports Third Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update

Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment

Jan 24, 2025, 8:45 AM EST - 1 year ago

Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment

Autonomix Medical, Inc. Finalizes Design of ASIC Microchip for Sensing Technology Catheter for Use in Humans, Continuing Progress Toward a U.S. Pivotal Trial in 2025

Jan 17, 2025, 8:00 AM EST - 1 year ago

Autonomix Medical, Inc. Finalizes Design of ASIC Microchip for Sensing Technology Catheter for Use in Humans, Continuing Progress Toward a U.S. Pivotal Trial in 2025

Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series

Jan 15, 2025, 8:30 AM EST - 1 year ago

Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series

Autonomix Medical, Inc. Announces Abstract Highlighting Preliminary Positive Clinical Results Accepted at The Society of Interventional Oncology (SIO) 2025 Annual Scientific Meeting

Jan 13, 2025, 8:30 AM EST - 1 year ago

Autonomix Medical, Inc. Announces Abstract Highlighting Preliminary Positive Clinical Results Accepted at The Society of Interventional Oncology (SIO) 2025 Annual Scientific Meeting

Autonomix Medical, Inc. Announces U.S. Patent Granted Covering the Treatment of Cancerous Tumors and Cancer Related Pain with Company's Proprietary Catheter-Based Technology

Dec 30, 2024, 8:30 AM EST - 1 year ago

Autonomix Medical, Inc. Announces U.S. Patent Granted Covering the Treatment of Cancerous Tumors and Cancer Related Pain with Company's Proprietary Catheter-Based Technology

Autonomix Medical, Inc. Achieves Design Lock for RF Ablation Catheter Following Successful Completion of Animal Testing, Continuing Progress Toward a U.S. Pivotal Trial in 2025

Dec 5, 2024, 8:30 AM EST - 1 year ago

Autonomix Medical, Inc. Achieves Design Lock for RF Ablation Catheter Following Successful Completion of Animal Testing, Continuing Progress Toward a U.S. Pivotal Trial in 2025

Autonomix Medical, Inc. Announces Closing of $10.0 Million Underwritten Public Offering Including Partial Exercise of Over-Allotment Option

Nov 25, 2024, 4:00 PM EST - 1 year ago

Autonomix Medical, Inc. Announces Closing of $10.0 Million Underwritten Public Offering Including Partial Exercise of Over-Allotment Option

Autonomix Medical, Inc. Announces Pricing of $9.0 Million Underwritten Public Offering

Nov 22, 2024, 9:15 AM EST - 1 year ago

Autonomix Medical, Inc. Announces Pricing of $9.0 Million Underwritten Public Offering

Autonomix Medical, Inc. Reports Second Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update

Nov 11, 2024, 8:00 AM EST - 1 year ago

Autonomix Medical, Inc. Reports Second Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update

Autonomix Medical, Inc.'s Dr. Robert Schwartz Discusses What Positive 4-6 Week Follow-Up Data Means from Lead-In Patients in Ongoing Human Clinical Trial

Oct 30, 2024, 8:30 AM EDT - 1 year ago

Autonomix Medical, Inc.'s Dr. Robert Schwartz Discusses What Positive 4-6 Week Follow-Up Data Means from Lead-In Patients in Ongoing Human Clinical Trial

Crude Oil Tumbles Over 5%; Autonomix Medical Shares Spike Higher

Oct 28, 2024, 12:06 PM EDT - 1 year ago

Crude Oil Tumbles Over 5%; Autonomix Medical Shares Spike Higher

Why Is Nao-Cap Neurology Focused Autonomix Medical Stock Trading Higher On Monday?

Oct 28, 2024, 11:08 AM EDT - 1 year ago

Why Is Nao-Cap Neurology Focused Autonomix Medical Stock Trading Higher On Monday?

Autonomix Medical, Inc. to Participate in a Virtual Investor “What This Means” Segment on Wednesday, October 30th

Oct 25, 2024, 11:30 AM EDT - 1 year ago

Autonomix Medical, Inc. to Participate in a Virtual Investor “What This Means” Segment on Wednesday, October 30th

Autonomix Announces Reverse Stock Split

Oct 22, 2024, 8:30 AM EDT - 1 year ago

Autonomix Announces Reverse Stock Split

Autonomix Medical, Inc. to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLC

Oct 8, 2024, 8:30 AM EDT - 1 year ago

Autonomix Medical, Inc. to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLC

GaryBx105
GaryBx105 Jan. 14 at 9:00 PM
$AMIX huge potential vs ongoing dilution. dilution winning - until today. maybe a turning point.
0 · Reply
darknite222
darknite222 Jan. 14 at 5:31 PM
$AMIX news update
0 · Reply
RISE07
RISE07 Jan. 14 at 4:41 PM
$AMIX I think something will happen after the J.P Morgan healthcare conference finish 🤔
0 · Reply
rangervs
rangervs Jan. 14 at 4:30 PM
$ROLR she’s moving! $AMIX bounce needs to happen!
0 · Reply
dwhall5056
dwhall5056 Jan. 14 at 2:22 PM
$AMIX looks like the dark pool has covered most of their shares ... https://fintel.io/ss/us/amix
0 · Reply
coolmate25
coolmate25 Jan. 14 at 4:31 AM
$AMIX This stock has been shortened to death already, I mean enough is enough. I have already disabled my stock lending and will request all investors and traders to disabled it too so that we can get something out of shorts squeeze.
0 · Reply
coolmate25
coolmate25 Jan. 13 at 8:02 PM
$AMIX All we need is a millionaire to invest on this hostoric dip and get multi-milliinare. Tax return comings.
0 · Reply
coolmate25
coolmate25 Jan. 13 at 6:12 PM
$AMIX Good price to buy right now . I wish if i had 100k right now.
0 · Reply
RISE07
RISE07 Jan. 13 at 5:43 PM
$AMIX buy and hold
0 · Reply
rangervs
rangervs Jan. 13 at 5:26 PM
$MNTS kept 1500 , promising $UAVS holding strong most of the day /will add more $AMIX near 52 week low , should bounce
0 · Reply
RISE07
RISE07 Jan. 12 at 8:46 PM
$AMIX
0 · Reply
CoolReally
CoolReally Jan. 12 at 2:43 PM
$AMIX lol, when is the reverse split?
0 · Reply
Pyrocity
Pyrocity Jan. 12 at 1:52 PM
$AMIX I mean this has a lot of potential didn’t really go on news though not sure what will push this up
0 · Reply
dwhall5056
dwhall5056 Jan. 12 at 2:38 AM
$AMIX Dr. Schwartz is a serial medical device inventor and developer of the Watchman™, a left atrial appendage closure device and proven one-time procedure that reduces the risk of stroke in non-valvular atrial fibrillation (NVAF) patients and the risk of bleeding that comes with a long-term oral anticoagulant use. The Watchman™ sold to Boston Scientific and has generated over $1 Billion in revenue. Compelling News: https://finance.yahoo.com/news/autonomix-showcases-compelling-poc-study-134500851.html
0 · Reply
rangervs
rangervs Jan. 11 at 6:13 PM
$AMIX under the radar still , great time to load up Buyout would send this !
0 · Reply
rangervs
rangervs Jan. 11 at 6:12 PM
$AMIX https://finance.yahoo.com/news/autonomix-showcases-compelling-poc-study-134500851.html
0 · Reply
BR_Research
BR_Research Jan. 11 at 12:39 AM
$AMIX $40 by 2028
1 · Reply
BR_Research
BR_Research Jan. 11 at 12:38 AM
$AMIX $AMIX First of its kind catheter utilizing ablation therapy to target nerves causing chronic pain resulting in near 100% opioid free pain management. IAM is roughly $3B with TAM roughly $90B. management has a good track record as well. Buyout in this sector typically run around $300M putting the stock price around $40 ultimately.
0 · Reply
BR_Research
BR_Research Jan. 11 at 12:30 AM
$AMIX
0 · Reply
N0F3AR
N0F3AR Jan. 10 at 4:30 PM
@StrategistBrady been quietly snapping lately🔥Worth a follow for sure! $AIRO $AMIX $ARBE $INBS Holds
0 · Reply
Bilwilly
Bilwilly Jan. 10 at 12:22 AM
$AMIX k’s. Whateer …lol
0 · Reply
Bilwilly
Bilwilly Jan. 10 at 12:14 AM
$AMIX 4 million $ on the bid …
0 · Reply